Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-1185-2014

Drug recall · April 9, 2014

Tivicay recall

Why: Cross Contamination with Other Products: Product contains Promacta (eltrombopag).

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Tivicay (dolutegravir) Tablets 50 mg, 30 Tablet Bottles, Rx Only. Manufactured for: ViiV Health, TRP, NC 27709; by: GlaxoSmithKline, Research Triangle Park, NC 27709. Made in Japan. NDC 49702-228-13

Lots / codes

Lot #: 3ZP2210 Sub-lot A, Expiry: 10/15

Quantity
1,056 bottles
Company
Viiv Healthcare Company, Durham, NC
Distribution
Nationwide including Puerto Rico
Initiated
February 11, 2014 · Voluntary: Firm initiated
Classified
April 1, 2014
Reported
April 9, 2014
Ended
August 21, 2014
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Tivicay

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.